Dr. Bruce Perler completed his internship and residency in general surgery, and a clinical and research fellowship in vascular surgery, at the Massachusetts General Hospital in Boston. Dr. Perler had edited several textbooks including Vascular Intervention: A Clinical Approach, Advances in Vascular Surgery, and Rutherfords Vascular Surgery. He is currently the Co-Editor of Rutherford's Textbook of Vascular Surgery and Endovascular Therapy, 9th edition. He has authored nearly 200 peer-reviewed medical journal articles and textbook chapters on the diagnosis and treatment of the entire spectrum of circulatory diseases. He serves on the Editorial Boards of several vascular surgical journals, and has most recently served as the Senior Editor of The Journal of Vascular Surgery, the Journal of Vascular Surgery: Venous and Lymphatic Disorders, and the Journal of Vascular Surgery Cases. He has delivered more than 200 lectures at national and international symposia and postgraduate courses. He serves on the Board of Directors of the Society for Vascular Surgery, and is past president of the Eastern Vascular Society the Southern Association for Vascular Surgery, and the Chesapeake Vascular Society. He also is the immediate past president of the Society for Vascular Surgery, the largest vascular surgical organization in the world with more than 5,400 members. In December 2015, he was named Associate Executive Director for Vascular Surgery of the American Board of Surgery (ABS). In this position, Dr. Perler oversees all ABS activities associated with vascular surgery assessment and board certification. He will continue to work at Johns Hopkins, both practicing vascular and endovascular surgery and in his departmental administrative position, while fulfilling this role at the ABS. “Dr. Perler’s vast experience in vascular surgery education will be a tremendous asset as we seek to continuously improve our certification and MOC processes for vascular surgeons,” said Dr. Frank R. Lewis, executive director of the American Board of Surgery at the time of the announcement. “We look forward to the contributions Dr. Perler will bring to the ABS.”. Dr. Perler is rated as a Distinguished provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Carotid Artery Disease, Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Stent Placement.

Dr. Thomas Stephen Metkus is an assistant professor of cardiology at the Johns Hopkins University School of Medicine. His research focuses on using cardiac physiology for risk stratification and therapeutics in non-cardiac critical illness such as sepsis and the acute respiratory distress syndrome (ARDS), and optimizing the management of non-cardiac organ failure in primary cardiac diseases such as heart failure and acute coronary syndromes. Dr. Metkus received his undergraduate degree from Boston University College of Engineering. He earned a medical degree from the University of Pennsylvania School of Medicine and completed a residency at Brigham and Women’s Hospital. After completing residency, Dr. Metkus was a clinical fellow at both Harvard Medical School and Johns Hopkins Hospital. Prior to joining the faculty at the Johns Hopkins Medical School he was an instructor of medicine at the Harvard Medical School. His educational focus includes teaching clinical cardiology and critical care, echocardiography, and electrocardiography to students, residents, and fellows at the Johns Hopkins Hospital. Videos Dr. Thomas Metkus. Dr. Metkus is rated as a Distinguished provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Dr. Jeffrey C. Trost is an associate professor of medicine at the Johns Hopkins School of Medicine as well as director of the Cardiac Catheterization Laboratory at Johns Hopkins Bayview Medical Center. His research there focuses on cardiac disease and cardiovascular medicine. He is also currently deputy director of clinical activities at Johns Hopkins Bayview Medical Center. Dr. Trost earned his undergraduate degree at Princeton University and medical degree at the University of Pennsylvania School of Medicine. He completed a residency at the University of Texas Southwestern School of Medicine where he was chief resident from 1999-2000. He was an assistant professor of internal medicine at the University of Texas Southwestern School of Medicine and an interventional cardiovascular fellow at Brown University before joining the Johns Hopkins faculty in 2005. Dr. Trost was most recently recognized with the 2016 Hopkins Medicine Clinical Recognition Award for Quality and Safety and the 2016 Hopkins Cardiology Fellows’ Teaching Award. Dr. Trost is rated as a Distinguished provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

Michael Zatina is a Vascular Surgeon and a General Surgeon in Baltimore, Maryland. Dr. Zatina is rated as a Distinguished provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Gangrene, Idiopathic Edema, Necrosis, Abdominal Aortic Aneurysm (AAA), and Carotid Artery Surgery. Dr. Zatina is currently accepting new patients.

"Originally from Wisconsin, Dr. Czarny attended the University of Wisconsin where he majored in molecular biology. After medical school at the Johns Hopkins University School of Medicine, he completed an internal medicine residency at the Brigham and Women’s Hospital in Boston followed by cardiovascular disease, interventional cardiology, and structural heart disease fellowships at Johns Hopkins. Currently, he is a faculty member in interventional cardiology and performs heart catheterizations and coronary artery stenting for patients with stable coronary artery disease (CAD) and myocardial infarctions (""heart attacks"") at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. He is also a member of the Structural Heart Disease team and performs minimally invasive, catheter-based treatments for structural heart disease at the Johns Hopkins Hospital including transcatheter aortic valve replacement (TAVR) for aortic valve stenosis, valve repair/replacement procedures for mitral valve regurgitation and stenosis, patent foramen ovale closure, atrial septal defect closure, alcohol septal ablation for hypertrophic cardiomyopathy, and left atrial appendage occlusion with the Watchman(TM) device. He sees patients in his structural heart disease clinics at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. Dr. Czarny's research interests include the safety of cardiac stenting at hospitals without cardiac surgery backup and outcomes of catheter-based structural heart procedures.". Dr. Czarny is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Jon R. Resar received his M.D. from the Medical College of Wisconsin in 1985. He completed an internal medicine residency at The Johns Hopkins Hospital and fellowships in cardiovascular medicine and interventional cardiology at The Johns Hopkins Hospital and Johns Hopkins University School of Medicine. He joined the faculty at Johns Hopkins in 1992 and is currently a Professor of Medicine/Cardiology. He was the past Director of the Adult Catheterization Laboratory and Interventional Cardiology at the Johns Hopkins Hospital. His field of specialization is management of coronary artery disease and valvular heart disease. Dr. Resar holds memberships in the American Heart Association and is a Fellow of the American College of Cardiology. Dr. Resar is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Hugh Calkins is the Catherine Ellen Poindexter Professor of Cardiology and Director of the Electrophysiology Laboratory and Arrhythmia Service at the Johns Hopkins Hospital. He is an internationally recognized expert on catheter ablation, atrial fibrillation, syncope, arrhythmogenic right ventricular dysplasia (ARVD) and arrhythmia management. Dr. Calkins attended Williams College and Harvard Medical School before training in medicine at Massachusetts General Hospital. He received his cardiology training at Johns Hopkins. His first faculty position was at the University of Michigan, where he directed the Pacemaker Service, and he returned to Johns Hopkins as director of the Arrhythmia Service in 1992. Dr. Calkins is an Associate Editor of the Journal of Cardiovascular Electrophysiology and is on the editorial board of many other cardiology journals. He is a former member of the American Board of Internal Medicine Electrophysiology Boards Test Writing Committee. Dr. Calkins is a fellow of the American College of Cardiology, the American Heart Association and the Heart Rhythm Society. He led a 44-member international task force whose 2012 Expert Consensus Statement gave recommendations for treatment and research of atrial fibrillation. Dr Calkins is a past president of the Heart Rhythm Society and was elected to be a member of the Miler Coulsen Academy of Clinical Excellence in 2014. Dr. Calkins has published more than 500 articles and book chapters on a large variety of cardiac arrhythmias. His research has focused predominantly on catheter ablation, atrial fibrillation, syncope, and arrhythmogenic right ventricular dysplasia. Dr. Calkins has also written extensively on most aspects of heart rhythm disorders and their treatment. Dr. Calkins is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Cardiomyopathy, Cardiac Ablation, and Heart Transplant.

Dr. Lum is a clinically busy vascular surgeon specializing in the open and endovascular treatment of peripheral arterial disease, cartoid artery disease, dialysis access, mesenteric occlusive disease, arterial aneurysms and venous disease. In addition, he has a strong clinical & research interest in thoracic outlet syndrome. Dr Lum also has a Masters in Public Health from the Johns Hopkins School of Public Health. Dr. Lum is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Thoracic Outlet Syndrome, Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Carotid Artery Surgery, and Osteotomy.

James Black is a Vascular Surgeon in Baltimore, Maryland. Dr. Black is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Aortic Dissection, Carotid Artery Surgery, and Hernia Surgery.

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Multifocal Atrial Tachycardia, Cardiac Ablation, and Tissue Biopsy.

Degrees: BS: Massachusetts Institute of Technology 1981 Electrical Engineering MS: Massachusetts Institute of Technology 1983 Electrical Engineering PhD: Massachusetts Institute of Technology 1987 Electrical Engineering MD: Harvard 1987 Medicine Professional Appointments: 1987-1988 Intern in Medicine, Brigham and Women's Hospital 1988-1990 Resident in Medicine, Brigham and Women's Hospital 1988-1990 Research Scientist, Harvard M.I.T. Division of H.S.T. 1990-1993 Fellow in Cardiology, Johns Hopkins University 1993-1998 Assistant Professor of Medicine, Johns Hopkins University 1996- Co-Director of Cardiac Electrophysiology, Johns Hopkins Hospital 1998-2005 Associate Professor of Medicine, Johns Hopkins University 2002-2005 Associate Professor of Biomedical Engineering, Johns Hopkins University 2005- Professor of Medicine, Johns Hopkins University 2005- Professor of Biomedical Engineering, Johns Hopkins University. Dr. Berger is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

Dr. Katherine Wu is a general cardiologist for the Heart and Vascular Institute at Johns Hopkins Medicine with an interest in caring for patients with cardiomyopathies, coronary artery disease, and valvular heart disease as well as those interested in cardiovascular prevention. She has additional expertise in non-invasive cardiology imaging techniques. Dr. Wu received her medical degree from the University of Pennsylvania Health System School of Medicine, and completed her residency and a cardiology fellowship at the Johns Hopkins University School of Medicine. She joined the School of Medicine faculty in 2000. Dr. Wu's research interests include improving individualized risk prediction for sudden cardiac death and heart failure by developing and validating methods that incorporate novel cardiac imaging indices. Her lab is funded by the NIH/NHLBI. Dr. Wu has more than 70 peer-reviewed publications and serves on the editorial board of the Journal of Cardiovascular Magnetic Resonance and Circulation Cardiovascular Imaging and is a standing member of the NIH Clinical and Integrative Cardiovascular Sciences Study Section. Dr. Wu is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. Her top areas of expertise are Cardiomyopathy, Atrial Fibrillation, Heart Attack, and Pulmonary Hypertension.

Dr. Abularrage specializes in vascular and endovascular surgery, with a specific interest in minimally invasive techniques for lower extremity peripheral arterial disease and aneurysm repair. His clinical interests include limb preservation, Diabetic peripheral arterial disease and limb salvage, aortic aneurysms, endovascular aneurysm repair, visceral stents and bypass, and carotid stents and carotid endarterectomy. Dr. Abularrage is an active researcher within the department and has published widely on outcomes research using large, national databases. Recently, Dr. Abularrage and his team have published their outcomes of patients treated in the Multidisciplinary Diabetic Foot & Wound Clinic, showing significantly lower amputation rates compared to national benchmarks. Dr. Abularrage is a distinguished fellow to the Society of the American Board of Surgery, and recipient of the Zehner Award and the R. Clement Darling, Jr. Award. He is nationally renowned for his work in Diabetic peripheral arterial disease and limb preservation. Dr. Abularrage is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Peripheral Artery Disease, Carotid Artery Disease, Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Stent Placement.

Rani Hasan is an Interventional Cardiologist in Baltimore, Maryland. Dr. Hasan is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Emmanouil Tampakakis is an Assistant Professor of Medicine at Johns Hopkins University School of Medicine as well as an attending physician at Johns Hopkins Hospital. His research focuses on Stem Cell Biology and Heart Development and Regeneration. Specifically, Dr. Tampakakis lab aims to understanding the biology and regenerative potential of stem cell-derived cardiomyocytes and uses human induced pluripotent stem cells and animal models to model human cardiac disease and deciphering the mechanisms of cardiac maturation. Dr. Tampakakis also holds a cardiology fellowship at Johns Hopkins Hospital. Dr. Tampakakis received his undergraduate degree and M.D. from the University of Crete. He completed an internal medicine residency at Boston University Medical Center. Prior to joining Johns Hopkins in 2012, Dr. Tampakakis was a research fellow in Dr. J. Vita’s laboratory of Vascular Biology at Boston University School of Medicine. At Johns Hopkins, he was a post-doc in the labs of Drs Chulan Kwon and David Kass. Dr. Tampakakis is the recipient of several awards including the AHA outstanding early career investigator award and the ACC Presidential Career Development Award and has received funding from the AHA and the NIH. Videos Meet Our Expert - Emmanouil Tampakakis Recent News Articles and Media Coverage Hopkins researchers discover newborn rats hold secret to manufacturing human heart cells., The Baltimore Sun, (February 11, 2017). Dr. Tampakakis is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, and Heart Failure.

Joseph Marine, MD, MBA, FACC, FHRS, is a clinical cardiac electrophysiologist who practices primarily at the Johns Hopkins Hospital in Baltimore, Maryland. He is a Professor of Medicine at the Johns Hopkins University School of Medicine and holds appointments as Vice-Director of Operations for the Division of Cardiology and Section Chief of Cardiology for Johns Hopkins Community Physicians. He trained at UC San Francisco Medical School, Brigham and Women’s Hospital/Harvard Medical School, Boston University Medical Center, and Beth Israel Deaconess Medical Center. Dr. Marine has lectured widely on a variety of arrhythmia topics and has served as a co-director of the American College of Cardiology (ACC) Cardiovascular Overview and Board Review Course for 10 years. He currently serves on the ACC Board of Governors and is co-editor of the ACC/HRS EP Self-Assessment Program. He also serves on other committees for the ACC, the Heart Rhythm Society, and MedChi. He is co-author of more than 130 original research and review articles and has served on writing committees for several national cardiology practice and training guidelines. As a clinical cardiac electrophysiologist, Dr. Marine specializes in the diagnosis and treatment of arrhythmias, which are heart rhythm disorders that cause the heart to beat too rapidly, too slowly, or irregularly. His research focuses on further improving the safety and effectiveness of catheter ablation and other treatments for atrial fibrillation and other atrial and ventricular arrhythmias. Dr. Marine is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Atrial Fibrillation, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Arrhythmias, Cardiac Ablation, and Heart Transplant.

Dr. Joao Lima is a professor of medicine, radiology and epidemiology at the Johns Hopkins School of Medicine. His pioneering work in cardiac imaging using advanced MRI, CT and echocardiography has led to noninvasive techniques for predicting cardiovascular disease and calculating its extent, as well as measuring the effectiveness of modern cardiac treatments. He holds numerous patents on devices and methods for cardiac imaging and image-guided therapies. Dr. Lima graduated medical school at the University of Bahia, Brazil. He completed his cardiology fellowship at Johns Hopkins and spent two years on the faculty of the University of Pennsylvania before returning to Hopkins as a faculty member in 1992. A long-time investigator with the Multi-Ethnic Study of Atherosclerosis (MESA), Dr. Lima is credited with more than 175 articles out of that study and nearly 575 publications over his career. He is associate editor of Journal of the American College of Cardiology and serves on the editorial board of the Italian Journal of Cardiology while reviewing for other journals including the New England Journal of Medicine, Circulation and Annals of Internal Medicine. Dr. Lima has been invited to present his research throughout the Americas, Europe and Asia. Dr. Lima is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Atherosclerosis, Heart Attack, Apoplexy, Heart Failure, and Bone Marrow Aspiration.

Dr. Gary Gerstenblith is professor of medicine and director of clinical trials in the Johns Hopkins Medicine Division of Cardiology. He also serves as attending physician in r the Cardiology care Unit. Dr. Gerstenblith earned his undergraduate degree from New York University and his medical degree from the University of Pennsylvania School of Medicine. After working at the National Institute on Aging and the National Institutes of Health (NIH) and completing a fellowship at Jackson Memorial Hospital in Miami, Dr. Gerstenblith joined the faculty of the Johns Hopkins University School of Medicine. Dr. Gerstenblith conducts clinical trials in patients with cardiovascular disease. His research interests include the impact of cardiovascular aging on cardiac structure and function, and the use of stem cells to repair damaged cardiac muscle. He has published nearly 250 articles and book chapters and has been a referee for numerous journals including Circulation, The New England Journal of Medicine and The Journal of the American College of Cardiology. Dr. Gerstenblith is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Heart Attack, Atherosclerosis, Coronary Heart Disease, Apoplexy, and Percutaneous Coronary Intervention (PCI).

Dr Halperin received the B.S degree in physics with highest distinction from Purdue University, the M.A. degree in physics from the University of California, Berkeley, and the M.D. degree from Louisiana State University, New Orleans, Louisiana. He is a member of Phi Beta Kappa, an Established Investigator and Fellow of the American Heart Association, and a McClure Fellow of the Johns Hopkins University Applied Physics laboratory. Dr. Halperin is currently a Professor of Medicine, Radiology and Biomedical Engineering at the Johns Hopkins Medical Institutions. He is the co-director of the Cardiovascular Imaging Center of Excellence. He serves on the editorial board of the journal Resuscitation, and is a past chair of the national American Heart Association Advanced Cardiovascular Life Support Subcommittee and a past member of the Emergency Cardiac Care Committee. Ten of his students have received young investigator awards from the American Heart Association and Heart Rhythm Society, and he has ongoing support from the National Institutes of Heath for his research programs. He has over 120 peer-reviewed publications and over 20 patents issued. Dr. Halperin is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Ventricular Fibrillation, Heart Attack, Ventricular Tachycardia, Cardiac Ablation, and Lithotripsy.

Maurizio Colognesi is a Cardiologist in Baltimore, Maryland. Dr. Colognesi is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Heart Failure, Heart Attack, Apoplexy, and Inappropriate Sinus Tachycardia (IST).